Answers are grounded in this paper and cite their sources.
Probiotics can have inflammatory activities in both healthy and IBD tissue. Valid preclinical data on proper model systems should therefore be obtained before specific probiotic strains enter the clinics, especially if administered during acute inflammatory responses. Postbiotics may be a safe alternative for the treatment of patients with IBD in the acute inflammatory phase.
No takes yet. Share an insight, caveat, or question.
Tsilingiri et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: